The global ”recombinant proteins market” size is estimated to flourish owing to the increasing research and development activities for developing advanced drugs to treat chronic diseases, observes Fortune Business Insights™ in an upcoming report, titled, “Recombinant Proteins Market Size, Share & Industry Analysis, By Type (Hormones, Growth Factors, Antibody, Enzyme, Others), By Application (Therapeutic, Research), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Others) and Regional Forecast 2020-2027.” The demand for protein production systems is increasing rapidly amid the COVID-19 pandemic owing to its utilization in the testing process.
The emergence of COVID-19 has brought the world to a standstill. The crisis has brought an unprecedented impact on Industries across the globe. While some industries are thriving in the current scenario, some are struggling to even run their operations. Stimulus packages from governments and support from several companies are being utilized to overcome the adversities.
At Fortune Business Insights, we are striving to help your business sustain amid the pandemic by offering a comprehensive report that includes a detailed impact analysis on the market.
Request a Sample Copy of the Research Report:
Increasing R&D in Pharmaceutical and Biotechnology Spaces to Aid North America Dominate
North America is estimated to lead the global recombinant proteins market due to the increasing research and development activities in pharmaceutical and biotechnology spaces. For instance, according to a research by Select USA, Over 800,000 people work in the biopharmaceutical industry in the U.S., including a broad range of occupations such as scientific research, technical support, and manufacturing.
Highlights of the Report:
This report incorporates an in-depth analysis of the overall growth prospects in the market. Furthermore, it provides insights into the comprehensive competitive landscape of the global market. A dashboard overview of leading companies, including their marketing strategies, market contribution, and recent developments is presented in both historic and present contexts.
Drivers & Restraints-
Rising Instances of Chronic Diseases Worldwide to Drive Growth
The increasing prevalence of chronic diseases across the world is expected to drive the growth of the global recombinant proteins market. For instance, as per a report published by the World Health Organization on chronic diseases and health promotion, chronic diseases are likely to account for 60% of the global burden of diseases. In addition, the rising demand for protein biologics is set to further strengthen growth. However, the challenges associated with the regulatory approvals are projected to limit growth.
Investing in R&D to Help Key Players Develop Therapeutic Drugs
The global recombinant proteins market comprises various manufacturers and businesses focused on offering advanced solutions to gain a competitive edge. Prominent players are investing in R&D to identify new applications of recombinant proteins in order to develop therapeutic products for several diseases. This will help them expand their product portfolios.
Have Any Query? Ask Our Experts:
- In June 2020, Lonza launched GSv9, a new media, to support the production of recombinant proteins using the company’s GS Gene expression system.
- In March 2020, AMS Biotechnology launched recombinant proteins and antibodies for the detection of the COVID-19 virus. The company offers a wide range of products including assays, recombinant proteins, and cell lines, particularly for drug development.
A List of Key Manufacturers Operating In the Global Recombinant Proteins Market Report:
- Sigma Aldrich Company Ltd.
- Novoprotein Scientific
- Thermo Fisher Scientific
- Merck KGaA
- Abcam PLC
- GenScript Biotech Corporation
- ProSpec Tany TechnoGene, Ltd.
Global Recombinant Proteins Market Segmentation :
- Growth Factors
By End User
- Biopharmaceutical Companies
- Academic & research Institutes
- North America (USA, Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and the Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and the Rest of Asia Pacific)
- Latin America (Brazil, Mexico, the Rest of Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
With tables and figures helping analyse worldwide Global recombinant proteins Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Related Reports :